Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Eric Linsley will participate on a panel titled "Leadership through Changing Times" at the Council for Entrepreneurial Development's Venture 2009 Conference in Pinehurst, NC
News | 04. 22. 2009
